Skip to content
Austin Top 50
Author:
Muscular Dystrophy Association
FDA Approves High Dose Regimen of SPINRAZA® for Spinal Muscular Atrophy, Reflecting Progress Made Possible Through Decades of MDA Supported Research
March 30, 2026
The 2026 MDA Clinical & Scientific Conference Highlights Breakthroughs in Neuromuscular Research, Innovative Therapies, and Patient Care
March 12, 2026
←
Previous Page
1
2